Company intelligence / Profile preview

Arcturis

San Diego, California, United Statesarcturis.com ↗

Ownership: Private
Development stage: Other

Overview

Arcturus has achieved commercial approval and launch of KOSTAIVE®, the world’s first self-amplifying mRNA COVID‑19 vaccine, with regulatory approvals in Japan and the EU. Its rare disease pipeline includes ARCT‑032 for cystic fibrosis and ARCT‑810 for OTC deficiency, both in Phase 2 clinical trials. The company’s platforms enable lower dosing and longer-lasting RNA therapies with strong safety profiles demonstrated in large-scale studies.

Therapeutic areas: PulmonologyMetabolic DisordersInfectious Diseases
Modalities: mRNA-based drugsSelf-amplifying mRNA (sa-mRNA)Lipid nanoparticle delivery therapy
Industry: Biotech

Partnerships

CSL Seqirus [COVID vaccine development/commercialization]Achilles Therapeutics plc [personalized cancer vaccines]Meiji Seika Pharma [regional partnership]Ultragenyx Pharmaceutical [rare disease collaboration]BARDA/Biomedical Advanced Research and Development Authority [pandemic preparedness support]

Beyond the preview

Go deeper on Arcturis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arcturis.

Explore the full profile